ARKG
ARK Genomic Revolution ETF, ticker ARKG, is an exchange-traded fund managed by ARK Investment Management LLC. It seeks long-term capital appreciation by investing in companies that enable the genomic revolution, including gene editing, sequencing, diagnostics, bioinformatics, and related life sciences services. The fund aims to identify disruptive innovations and allocate capital to firms expected to benefit from breakthroughs in genomics.
Investment approach and holdings: ARKG employs an active, research-driven strategy with a high-conviction, growth-oriented portfolio. It
Performance and risk: As with many biotechnology-focused investments, ARKG can be volatile and sensitive to regulatory
Background: ARK Genomic Revolution ETF is part of ARK Investment Management’s family of thematic ETFs focused